EU reaches accord on stricter regulations for medtech, IVDs
PARIS The European Union reached agreement on the reform of regulations for the CE mark that governs the commercialization of medical devices and in vitro diagnostic tests (IVDs) in the world's second-largest market.
Boston Scientific flies the W flag
It took 10 years but Boston Scientific (BSX) may have finally overcome its ill-advised 2006 Guidant acquisition. The company's shares hit a decade high Wednesday, at one point spiking nearly 12 percent to $22.05 after knocking its first quarter sales out of the park. (MDD Perspectives)
Growing evidence supports clinical potential of new cancer tests
With a market opportunity in the billions (as much as $20 billion by some estimates), diagnostic companies are rushing the liquid biopsy floodgates with new tests designed to make finding and monitoring cancer as easy as a blood draw or urine sample. This week, in a two-part series, Medical Device Daily will explore both the business opportunities and the clinical potential of this growing market.